Literature DB >> 15138893

Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.

Maria A Rettenbacher1, Tom Burns, Georg Kemmler, W Wolfgang Fleischhacker.   

Abstract

BACKGROUND: Non-compliance with antipsychotic medication is known to be one of the major reasons for relapse in patients with schizophrenia. Carers might be able to reduce noncompliance by enhancing the patient's knowledge about the illness and antipsychotic medication and by carrying out regular benefit/risk discussions concerning the treatment plan, thereby improving the patient's attitudes towards pharmacological treatment.
METHODS: In this cross-sectional study we used a semistructured interview to investigate the attitudes towards the illness and antipsychotic medication of patients with schizophrenia and of medical and non-medical professionals involved in their treatment. An array of 24 outpatients with schizophrenia, 21 psychiatrists, 26 nurses and 42 non-medical health professionals were investigated.
RESULTS: We found compliance in 54.2%, partial compliance in 8.3% and non-compliance in 37.5% of patients. More patients than carers judged other disorders like epilepsy and diabetes to be worse than schizophrenia. Patients stated more often, that they would not encourage a relative to take antipsychotic medication. An extent of 71.4% of psychiatrists and 35% of non-medical professionals reported a general willingness to take antipsychotic medication themselves, if they were to suffer from schizophrenia.
CONCLUSIONS: Our results indicate that the attitude of carers is not only different from patients but also remarkably heterogeneous within the group of carers. This needs to be taken into account when planning compliance-enhancing measures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138893     DOI: 10.1055/s-2004-818987

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  12 in total

1.  Medical care for patients with severe and persistent mental illness.

Authors:  Sahana Misra; Linda Ganzini
Journal:  J Gen Intern Med       Date:  2006-11       Impact factor: 5.128

2.  WPA guidance on how to combat stigmatization of psychiatry and psychiatrists.

Authors:  Norman Sartorius; Wolfgang Gaebel; Helen-Rose Cleveland; Heather Stuart; Tsuyoshi Akiyama; Julio Arboleda-Flórez; Anja E Baumann; Oye Gureje; Miguel R Jorge; Marianne Kastrup; Yuriko Suzuki; Allan Tasman
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

3.  Adherence/compliance: a multifaceted challenge.

Authors:  W Wolfgang Fleischhacker
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

4.  Non-compliance in pharmacotherapy.

Authors:  M S Reddy
Journal:  Indian J Psychol Med       Date:  2012-04

5.  Attitudes toward metabolic adverse events among patients with schizophrenia in Japan.

Authors:  Norio Sugawara; Norio Yasui-Furukori; Manabu Yamazaki; Kazutaka Shimoda; Takao Mori; Takuro Sugai; Hiroshi Matsuda; Yutaro Suzuki; Yoshitake Minami; Yuji Ozeki; Kurefu Okamoto; Toyoaki Sagae; Toshiyuki Someya
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-24       Impact factor: 2.570

6.  Assessment of impact of pharmacophilia and pharmacophobia on medication adherence in patients with psychiatric disorders: A cross-sectional study.

Authors:  Mini Johnson Christudas; Balaji Sathyanarayana Gupta; Krishna Undela; Noel M Isaac; Dushad Ram; Madhan Ramesh
Journal:  Indian J Pharmacol       Date:  2016 Nov-Dec       Impact factor: 1.200

7.  The role of the affective temperament in the treatment adherence in psychiatry.

Authors:  Lilia Bahrini; Rahma Damak; Mejda Cheour
Journal:  Pan Afr Med J       Date:  2016-09-02

8.  Treatment outcomes in schizophrenia: qualitative study of the views of family carers.

Authors:  Joanne Lloyd; Helen Lloyd; Ray Fitzpatrick; Michele Peters
Journal:  BMC Psychiatry       Date:  2017-07-21       Impact factor: 3.630

9.  Predictors of pharmacophobia.

Authors:  Ana Petelinšek; Anita Lauri Korajlija
Journal:  Health Psychol Res       Date:  2020-05-26

10.  Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder.

Authors:  A Carlo Altamura; Jose M Goikolea
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.